- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05582395
Un estudio de mavacamten en la miocardiopatía hipertrófica no obstructiva (ODYSSEY-HCM)
Estudio clínico aleatorizado, doble ciego, controlado con placebo para evaluar mavacamten en adultos con miocardiopatía hipertrófica no obstructiva sintomática
The purpose of this study is to evaluate the safety, tolerability, and efficacy of mavacamten compared with placebo in participants with symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM).
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- Fase 3
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Berlin, Alemania, 13353
- Local Institution - 0403
-
Freiburg im Breisgau, Alemania, 79106
- Local Institution - 0071
-
Hamburg, Alemania, 20246
- Local Institution - 0032
-
Heidelberg, Alemania, 69120
- Local Institution - 0077
-
München, Alemania, 80636
- Local Institution - 0454
-
Münster, Alemania, 48149
- Local Institution - 0046
-
-
Baden-Wurttemberg
-
Ulm, Baden-Wurttemberg, Alemania, 89081
- Local Institution - 0404
-
-
Bavaria
-
München, Bavaria, Alemania, 81377
- Local Institution - 0022
-
Regensburg, Bavaria, Alemania, 93053
- Local Institution - 0440
-
-
Hesse
-
Bad Nauheim, Hesse, Alemania, 61231
- Local Institution - 0013
-
-
Lower Saxony
-
Göttingen, Lower Saxony, Alemania, 37075
- Local Institution - 0496
-
Hanover, Lower Saxony, Alemania, 30625
- Local Institution - 0448
-
-
North Rhine Wesrphalia
-
Cologne, North Rhine Wesrphalia, Alemania, 50924
- Local Institution - 0273
-
-
North Rhine-Westphalia
-
Bad Oeynhausen, North Rhine-Westphalia, Alemania, 32545
- Local Institution - 0439
-
Bielefeld, North Rhine-Westphalia, Alemania, 33604
- Local Institution - 0174
-
-
Rhineland-Palatinate
-
Mainz, Rhineland-Palatinate, Alemania, 55131
- Local Institution - 0420
-
-
Schleswig-Holstein
-
Lübeck, Schleswig-Holstein, Alemania, 23538
- Local Institution - 0066
-
-
Thuringia
-
Jena, Thuringia, Alemania, 07747
- Local Institution - 0016
-
-
-
-
New South Wales
-
Concord, New South Wales, Australia, 2139
- Local Institution - 0063
-
Darlinghurst, New South Wales, Australia, 2010
- Local Institution - 0085
-
Sydney, New South Wales, Australia, 2170
- Local Institution - 0369
-
-
Queensland
-
Chermside, Queensland, Australia, 4032
- Local Institution - 0080
-
Milton, Queensland, Australia, 4064
- Local Institution - 0078
-
-
South Australia
-
Bedford Park, South Australia, Australia, 5042
- Local Institution - 0050
-
-
Western Australia
-
Murdoch, Western Australia, Australia, 6150
- Local Institution - 0076
-
-
-
-
-
Graz, Austria, 8036
- Local Institution - 0062
-
Vienna, Austria, 1090
- Local Institution - 0429
-
-
Tyrol
-
Innsbruck, Tyrol, Austria, 6020
- Local Institution - 0090
-
-
Upper Austria
-
Linz, Upper Austria, Austria, 4020
- Local Institution - 0075
-
-
Upper Austria (Oberösterreich)
-
Braunau am Inn, Upper Austria (Oberösterreich), Austria, 5280
- Local Institution - 0069
-
-
-
-
-
Rio de Janeiro, Brasil, 22061-080
- Local Institution - 0451
-
Rio de Janeiro, Brasil, 20551-030
- Local Institution - 0446
-
São Paulo, Brasil, 04012-180
- Local Institution - 0418
-
-
Estado de Bahia
-
Salvador, Estado de Bahia, Brasil, 40170-130
- Local Institution - 0413
-
-
Federal District
-
Brasília, Federal District, Brasil, 70710-140
- Local Institution - 0438
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brasil, 30220-140
- Local Institution - 0488
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brasil, 90560-030
- Local Institution - 0447
-
Porto Alegre, Rio Grande do Sul, Brasil, 90620-001
- Local Institution - 0450
-
-
São Paulo
-
Bragança Paulista, São Paulo, Brasil, 12916-542
- Local Institution - 0430
-
Ribeirão Preto, São Paulo, Brasil, 14026-900
- Local Institution - 0422
-
São Paulo, São Paulo, Brasil, 05403-000
- Local Institution - 0412
-
-
-
-
Antwerpen
-
Edegem, Antwerpen, Bélgica, 2650
- Local Institution - 0462
-
-
Brussels Capital
-
Anderlecht, Brussels Capital, Bélgica, 1070
- Local Institution - 0034
-
-
Limburg
-
Genk, Limburg, Bélgica, 3600
- Local Institution - 0476
-
-
Vlaams Brabant
-
Leuven, Vlaams Brabant, Bélgica, 3000
- Local Institution - 0319
-
-
-
-
Alberta
-
Calgary, Alberta, Canadá, T2N 1N4
- Local Institution - 0381
-
-
British Columbia
-
Vancouver, British Columbia, Canadá, V6E 1M7
- Local Institution - 0467
-
-
Ontario
-
Hamilton, Ontario, Canadá, L8L 2X2
- Local Institution - 0414
-
London, Ontario, Canadá, N6A 5A5
- Local Institution - 0411
-
-
Quebec
-
Québec, Quebec, Canadá, G1V 4G5
- Local Institution - 0093
-
-
-
-
-
Brno, Chequia, 656 91
- Local Institution - 0188
-
-
Hradec Králové Region
-
Broumov, Hradec Králové Region, Chequia, 550 01
- Local Institution - 0086
-
-
Praha, Hlavní Mesto
-
Prague, Praha, Hlavní Mesto, Chequia, 140 21
- Local Institution - 0033
-
Prague, Praha, Hlavní Mesto, Chequia, 128 21
- Local Institution - 0052
-
-
-
-
-
Busan, Corea del Sur, 49241
- Local Institution - 0517
-
Seongnam-si, Corea del Sur
- Local Institution - 0508
-
Seoul, Corea del Sur, 03080
- Local Institution - 0217
-
Seoul, Corea del Sur, 05505
- Local Institution - 0049
-
-
Daegu Gwang'yeogsi
-
Daegu, Daegu Gwang'yeogsi, Corea del Sur, 42601
- Local Institution - 0516
-
-
Incheon Gwang'yeogsi
-
Incheon, Incheon Gwang'yeogsi, Corea del Sur, 22332
- Local Institution - 0518
-
-
Seoul Teugbyeolsi
-
Seoul, Seoul Teugbyeolsi, Corea del Sur, 03722
- Local Institution - 0012
-
Seoul, Seoul Teugbyeolsi, Corea del Sur, 6351
- Local Institution - 0055
-
Seoul, Seoul Teugbyeolsi, Corea del Sur, 6591
- Local Institution - 0460
-
-
-
-
-
Aarhus N, Dinamarca, 8200
- Local Institution - 0019
-
-
North Denmark
-
Aalborg, North Denmark, Dinamarca, DK-9000
- Local Institution - 0045
-
-
Sønderjylland
-
Aabenraa, Sønderjylland, Dinamarca, 6200
- Local Institution - 0428
-
-
-
-
-
A Coruña, España, 15006
- Local Institution - 0043
-
Alicante, España, 03010
- Local Institution - 0087
-
Barcelona, España, 08035
- Local Institution - 0018
-
Barcelona, España, 08036
- Local Institution - 0056
-
Granada, España, 18014
- Local Institution - 0060
-
Madrid, España, 28034
- Local Institution - 0421
-
Málaga, España, 29010
- Local Institution - 0041
-
Salamanca, España, 37007
- Local Institution - 0031
-
Seville, España, 41009
- Local Institution - 0051
-
Valencia, España, 46026
- Local Institution - 0027
-
-
Balearic Islands
-
Palma de Mallorca, Balearic Islands, España, 07198
- Local Institution - 0040
-
-
Barcelona
-
L'Hospitalet de Llobregat, Barcelona, España, 08907
- Local Institution - 0299
-
-
Madrid
-
Majadahonda, Madrid, España, 28222
- Local Institution - 0021
-
-
Murcia
-
El Palmar, Murcia, España, 30120
- Local Institution - 0237
-
-
-
-
Alabama
-
Birmingham, Alabama, Estados Unidos, 35233-1900
- Local Institution - 0082
-
-
Arizona
-
Phoenix, Arizona, Estados Unidos, 85054
- Local Institution - 0458
-
-
California
-
La Jolla, California, Estados Unidos, 92037-1337
- Local Institution - 0409
-
Los Angeles, California, Estados Unidos, 90048-3311
- Local Institution - 0010
-
San Francisco, California, Estados Unidos, 94143-2204
- Local Institution - 0406
-
Stanford, California, Estados Unidos, 94305-2200
- Local Institution - 0079
-
-
Florida
-
Gainesville, Florida, Estados Unidos, 32608-1134
- Local Institution - 0468
-
Tampa, Florida, Estados Unidos, 33606-3603
- Local Institution - 0281
-
-
Georgia
-
Atlanta, Georgia, Estados Unidos, 30322
- Local Institution - 0092
-
-
Indiana
-
Indianapolis, Indiana, Estados Unidos, 46202-1243
- Local Institution - 0424
-
-
Iowa
-
Iowa City, Iowa, Estados Unidos, 52242-1009
- Local Institution - 0070
-
-
Kansas
-
Kansas City, Kansas, Estados Unidos, 66160-8500
- Local Institution - 0410
-
-
Kentucky
-
Louisville, Kentucky, Estados Unidos, 40217-1363
- Local Institution - 0484
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21287
- Local Institution - 0127
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02114
- Local Institution - 0479
-
Boston, Massachusetts, Estados Unidos, 02118-2908
- Local Institution - 0500
-
-
Michigan
-
Ann Arbor, Michigan, Estados Unidos, 48109
- Local Institution - 0464
-
Detroit, Michigan, Estados Unidos, 48202-2608
- Local Institution - 0064
-
Grand Rapids, Michigan, Estados Unidos, 49525
- Local Institution - 0455
-
-
Minnesota
-
Rochester, Minnesota, Estados Unidos, 55905
- Local Institution - 0431
-
-
Missouri
-
St Louis, Missouri, Estados Unidos, 63110
- Local Institution - 0461
-
-
Nebraska
-
Omaha, Nebraska, Estados Unidos, 68198-2265
- Local Institution - 0435
-
-
New Jersey
-
Morristown, New Jersey, Estados Unidos, 07962
- Local Institution - 0490
-
-
New York
-
Manhasset, New York, Estados Unidos, 11030-3816
- Local Institution - 0449
-
New York, New York, Estados Unidos, 10019-1147
- Local Institution - 0486
-
Stony Brook, New York, Estados Unidos, 11790-3407
- Local Institution - 0007
-
Valhalla, New York, Estados Unidos, 10595
- Local Institution - 0426
-
-
North Carolina
-
Charlotte, North Carolina, Estados Unidos, 28204-2826
- Local Institution - 0094
-
Durham, North Carolina, Estados Unidos, 27710
- Local Institution - 0065
-
-
Ohio
-
Cleveland, Ohio, Estados Unidos, 44195
- Local Institution - 0083
-
-
Pennsylvania
-
Hershey, Pennsylvania, Estados Unidos, 17033
- Local Institution - 0047
-
Lancaster, Pennsylvania, Estados Unidos, 17602-2250
- Local Institution - 0444
-
Philadelphia, Pennsylvania, Estados Unidos, 19104
- Local Institution - 0263
-
Pittsburgh, Pennsylvania, Estados Unidos, 15213-2536
- Local Institution - 0081
-
-
Tennessee
-
Germantown, Tennessee, Estados Unidos, 38138-1727
- Local Institution - 0207
-
-
Texas
-
Dallas, Texas, Estados Unidos, 75246
- Local Institution - 0089
-
Dallas, Texas, Estados Unidos, 75390
- Local Institution - 0365
-
Plano, Texas, Estados Unidos, 75093
- Local Institution - 0492
-
-
Utah
-
Salt Lake City, Utah, Estados Unidos, 84132-0001
- Local Institution - 0402
-
-
Virginia
-
Charlottesville, Virginia, Estados Unidos, 22908-0001
- Local Institution - 0478
-
Richmond, Virginia, Estados Unidos, 23298-5024
- Local Institution - 0095
-
-
-
-
-
Nantes, Francia, 44093
- Local Institution - 0009
-
Paris, Francia, 75013
- Local Institution - 0004
-
Paris, Francia, 75015
- Local Institution - 0006
-
Pessac, Francia, 33604
- Local Institution - 0053
-
Rennes, Francia, 35000
- Local Institution - 0008
-
-
Alpes-Maritimes
-
Nice, Alpes-Maritimes, Francia, 06000
- Local Institution - 0001
-
-
Finistère
-
Brest, Finistère, Francia, 29200
- Local Institution - 0463
-
-
Haute-Garonne
-
Toulouse, Haute-Garonne, Francia, 31400
- Local Institution - 0005
-
-
Indre-et-Loire
-
Chambray-lès-Tours, Indre-et-Loire, Francia, 37044
- Local Institution - 0003
-
-
Isère
-
La Tronche, Isère, Francia, 38700
- Local Institution - 0489
-
-
Rhône
-
Bron, Rhône, Francia, 69500
- Local Institution - 0067
-
-
-
-
-
Budapest, Hungría, 1096
- Local Institution - 0048
-
Budapest, Hungría, 1097
- Local Institution - 0039
-
Budapest, Hungría, 1122
- Local Institution - 0035
-
Szeged, Hungría, 6720
- Local Institution - 0417
-
-
Veszprém megye
-
Balatonfüred, Veszprém megye, Hungría, 8230
- Local Institution - 0423
-
-
-
-
-
Chandigarh, India, 160012
- Local Institution - 0483
-
Gūrgaon, India, 122 001
- Local Institution - 0330
-
-
Gujarat
-
Ahmedabad, Gujarat, India, 380060
- Local Institution - 0482
-
-
Karnataka
-
Bengaluru, Karnataka, India, 560099
- Local Institution - 0480
-
-
Kerala
-
Kochi, Kerala, India, 682001
- Local Institution - 0481
-
-
-
-
-
Haifa, Israel, 3109601
- Local Institution - 0419
-
Petah Tikva, Israel, 49100
- Local Institution - 0427
-
Ramat Gan, Israel, 5265601
- Local Institution - 0074
-
Rehovot, Israel, 76100
- Local Institution - 0054
-
Safed, Israel, 13100
- Local Institution - 0253
-
-
Jerusalem
-
Jerusalem, Jerusalem, Israel, 90000
- Local Institution - 0025
-
Jerusalem, Jerusalem, Israel, 9103102
- Local Institution - 0057
-
-
Tel Aviv
-
Ashkelon, Tel Aviv, Israel, 7830604
- Local Institution - 0026
-
Tel Aviv, Tel Aviv, Israel, 6423906
- Local Institution - 0037
-
-
-
-
-
Pisa, Italia, 56124
- Local Institution - 0171
-
Roma, Italia, 00189
- Local Institution - 0028
-
-
Tuscany
-
Florence, Tuscany, Italia, 50139
- Local Institution - 0373
-
-
-
-
-
Fukuoka, Japón, 810-0001
- Local Institution - 0521
-
-
Ehime
-
Uwajima, Ehime, Japón, 798-8510
- Local Institution - 0370
-
-
Hyōgo
-
Himeji-Shi, Hyōgo, Japón, 672-8044
- Local Institution - 0208
-
-
Ishikawa-ken
-
Kanazawa, Ishikawa-ken, Japón, 920-8641
- Local Institution - 0457
-
-
Kanagawa
-
Yokohama, Kanagawa, Japón, 227-8501
- Local Institution - 0107
-
-
Kochi
-
Nankoku-shi, Kochi, Japón, 783-8505
- Local Institution - 0119
-
-
Mie-ken
-
Tsu, Mie-ken, Japón, 514-8507
- Local Institution - 0453
-
-
Miyagi
-
Sendai, Miyagi, Japón, 980-8574
- Local Institution - 0456
-
-
Osaka
-
Osaka, Osaka, Japón, 545-0051
- Local Institution - 0452
-
Suita, Osaka, Japón, 564-8565
- Local Institution - 0315
-
Takatsuki-Shi, Osaka, Japón, 569-8686
- Local Institution - 0471
-
-
Shizuoka
-
Hamamatsu, Shizuoka, Japón, 431-3192
- Local Institution - 0168
-
-
Tokyo
-
Bunkyo-ku, Tokyo, Japón, 1138603
- Local Institution - 0477
-
Chuo-Ku, Tokyo, Japón, 104-0044
- Local Institution - 0505
-
Koto-Ku, Tokyo, Japón, 135-0061
- Local Institution - 0466
-
Shinjuku-ku, Tokyo, Japón, 160-8582
- Local Institution - 0314
-
Shinjuku-ku, Tokyo, Japón, 162-8666
- Local Institution - 0475
-
tabashi City, Tokyo, Japón, 173-0003
- Local Institution - 0224
-
-
-
-
-
Lørenskog, Noruega, 1478
- Local Institution - 0443
-
Oslo, Noruega, 0424
- Local Institution - 0441
-
Trondheim, Noruega, 7030
- Local Institution - 0473
-
-
-
-
-
Utrecht, Países Bajos, 3584 CX
- Local Institution - 0061
-
-
Gelderland
-
Nijmegen, Gelderland, Países Bajos, 6525 GA
- Local Institution - 0442
-
-
Limburg
-
Maastricht, Limburg, Países Bajos, 6229 HX
- Local Institution - 0434
-
-
North Holland
-
Amsterdam-Zuidoost, North Holland, Países Bajos, 1105 AZ
- Local Institution - 0197
-
-
South Holland
-
Rotterdam, South Holland, Países Bajos, 3015 GD
- Local Institution - 0213
-
-
-
-
-
Bialystok, Polonia, 15-276
- Local Institution - 0030
-
Lódz, Polonia, 93-338
- Local Institution - 0416
-
-
Lesser Poland Voivodeship
-
Krakow, Lesser Poland Voivodeship, Polonia, 31-202
- Local Institution - 0042
-
-
Lower Silesian Voivodeship
-
Wroclaw, Lower Silesian Voivodeship, Polonia, 50-556
- Local Institution - 0038
-
Wroclaw, Lower Silesian Voivodeship, Polonia, 50-981
- Local Institution - 0091
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, Polonia, 02-097
- Local Institution - 0338
-
Warsaw, Masovian Voivodeship, Polonia, 02-507
- Local Institution - 0203
-
-
Podkarpackie Voivodeship
-
Rzeszów, Podkarpackie Voivodeship, Polonia, 35-055
- Local Institution - 0072
-
-
Silesian Voivodeship
-
Katowice, Silesian Voivodeship, Polonia, 40-555
- Local Institution - 0017
-
Zabrze, Silesian Voivodeship, Polonia, 41-800
- Local Institution - 0415
-
-
Łódź Voivodeship
-
Lodz, Łódź Voivodeship, Polonia, 91-347
- Local Institution - 0059
-
-
-
-
-
Beijing, Porcelana, 100730
- Local Institution - 0502
-
Beijing, Porcelana, 102218
- Local Institution - 0553
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Porcelana, 100083
- Local Institution - 0535
-
Beijing, Beijing Municipality, Porcelana, 100730
- Local Institution - 0534
-
-
Chongqing Municipality
-
Chongqing, Chongqing Municipality, Porcelana, 400016
- Local Institution - 0503
-
Chongqing, Chongqing Municipality, Porcelana, 400016
- Local Institution - 0541
-
-
Guangdong
-
Guangzhou, Guangdong, Porcelana, 510120
- Local Institution - 0539
-
Guangzhou, Guangdong, Porcelana, 510515
- Local Institution - 0543
-
-
Henan
-
Zhengzhou, Henan, Porcelana, 450003
- Local Institution - 0549
-
-
Hubei
-
Wuhan, Hubei, Porcelana, 430060
- Local Institution - 0542
-
-
Hunan
-
Changsha, Hunan, Porcelana, 410011
- Local Institution - 0548
-
-
Jiangsu
-
Suzhou, Jiangsu, Porcelana, 215006
- Local Institution - 0545
-
-
Jiangxi
-
Nanchang, Jiangxi, Porcelana, 330008
- Local Institution - 0550
-
-
Jilin
-
Changchun, Jilin, Porcelana, 130041
- Local Institution - 0544
-
-
Liaoning
-
Dalian, Liaoning, Porcelana, 116011
- Local Institution - 0540
-
Shenyang, Liaoning, Porcelana, 110016
- Local Institution - 0501
-
Shenyang, Liaoning, Porcelana, 110016
- Local Institution - 0538
-
-
Shan1xi
-
Xi'an, Shan1xi, Porcelana, 710061
- Local Institution - 0547
-
-
Shandong
-
Jinan, Shandong, Porcelana, 250021
- Local Institution - 0546
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Porcelana, 200127
- Local Institution - 0537
-
-
Sichuan
-
Chengdu, Sichuan, Porcelana, 610000
- Local Institution - 0533
-
Chengdu, Sichuan, Porcelana, 610015
- Local Institution - 0552
-
-
Zhejiang
-
Wenzhou, Zhejiang, Porcelana, 325000
- Local Institution - 0536
-
-
-
-
-
Almada, Portugal, 2805-267
- Local Institution - 0015
-
Leiria, Portugal, 2410-197
- Local Institution - 0433
-
Lisbon, Portugal, 1500-650
- Local Institution - 0023
-
Lisbon, Portugal, 1649-035
- Local Institution - 0024
-
Vila Nova de Gaia, Portugal, 4434-502
- Local Institution - 0014
-
-
Braga District
-
Guimarães, Braga District, Portugal, 4835-044
- Local Institution - 0044
-
-
-
-
-
Birmingham, Reino Unido, B15 2TH
- Local Institution - 0407
-
London, Reino Unido, EC1A 7BE
- Local Institution - 0472
-
-
Greater London
-
London, Greater London, Reino Unido, SW3 6NP
- Local Institution - 0445
-
-
Lanarkshire
-
Glasgow, Lanarkshire, Reino Unido, G51 4TF
- Local Institution - 0073
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria
- Diagnosis of HCM consistent with current American College of Cardiology Foundation/American Heart Association and European Society of Cardiology guidelines: unexplained left-ventricular hypertrophy with non-dilated ventricular chambers in the absence of other cardiac or systemic disease which can produce the required magnitude of hypertrophy of a maximal left ventricular (LV) wall thickness ≥ 15 millimeters (mm) (or ≥ 13 mm with positive family history of hypertrophic cardiomyopathy [HCM]) as determined by core laboratory interpretation.
- Peak left ventricular outflow tract (LVOT) pressure gradient < 30 millimeters mercury (mm Hg) at rest and < 50 mm Hg with provocation (Valsalva maneuver and stress echocardiography).
- New York Heart Association (NYHA) Class II or III.
Exclusion Criteria
- Known infiltrative or storage disorder causing cardiac hypertrophy that mimics non-obstructive hypertrophic cardiomyopathy (nHCM) such as Fabry disease, amyloidosis, or Noonan syndrome with LV hypertrophy.
- History of unexplained syncope within 6 months prior to screening.
- History of sustained ventricular tachyarrhythmia (> 30 seconds) within 6 months prior to screening.
- Other protocol-defined Inclusion/Exclusion criteria apply.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador de placebos: Placebo
|
Specified dose on specified days |
|
Experimental: Mavacamtén
|
Specified dose on specified days
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change From Baseline in KCCQ-23 CSS at Week 48
Periodo de tiempo: From First dose to week 48
|
The KCCQ-23 is a 23-item, self-administered questionnaire that measures the impact of a participant's cardiovascular disease or its treatment on 6 distinct domains using a 2-week recall period: symptoms/signs, physical limitation, quality of life (QoL), social limitations, self-efficacy, and symptom stability. The KCCQ 23 Clinical Summary Score (CSS) is derived from the Total Symptom Score (TSS) and the Physical Limitations (PL) score of the KCCQ 23. The CSS, TSS, and the PL score range from 0 to 100 with higher scores representing less severe symptoms and/or physical limitations. The CSS is a mean of the TSS and the PL score. Baseline is defined as the last non-missing assessment prior to the first dose of the study treatment if both the time of the measurement and the time of first dose are available otherwise it is the last non-missing assessment on or prior to the first dose of the study treatment. |
From First dose to week 48
|
|
Change From Baseline in pVO2 at Week 48
Periodo de tiempo: From First dose to week 48
|
Clinically meaningful mean change from baseline(1.4ml/kg/min) of pVO2 at Week 48. |
From First dose to week 48
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change From Baseline in VE/VCO2 Slope at Week 48
Periodo de tiempo: From First dose to week 48
|
VE/VCO₂ slope was assessed using cardiopulmonary exercise testing (CPET). The slope was calculated as the linear regression of minute ventilation (VE) against carbon dioxide production (VCO₂). A decrease in VE/VCO₂ slope reflects improved ventilatory efficiency. |
From First dose to week 48
|
|
Mean Change From Baseline in NT-proBNP to Week 48
Periodo de tiempo: From First dose to week 48
|
Blood samples were collected for assessing the concentration of NT-proBNP. Baseline is defined as last non-missing measurement prior to the first dose. |
From First dose to week 48
|
|
Percentage of Participants With at Least 1 Class of NYHA Improvement From Baseline at Week 48
Periodo de tiempo: From First dose to week 48
|
Participants with \>= 1 NYHA function class improvement. The NYHA Functional Classification of heart failure assigns participants to 1 of 4 categories based on the participant's symptoms. Class 1: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath). Class 2: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath). Class 3: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea. Class 4: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases. |
From First dose to week 48
|
|
Mean Change From Baseline in HCMSQ SoB Domain Score at Week 48
Periodo de tiempo: From First dose to week 48
|
The HCMSQ is a self- administered, 9-item questionnaire that assesses the core symptoms of HCM (shortness of breath, tiredness/fatigue, heart palpitations, chest pain, dizziness, and syncope). At each visit, a 7-day period will be defined, ending on the last day with a non-missing HCMSQ score prior to the actual clinic visit (or first dose date if baseline). If the participant completes the HCMSQ for 4 or more days within this period, the weekly average HCMSQ score will be calculated. If fewer than 4 days are completed, other 7-day periods will be considered. For baseline, any 7-day period with at least 4 days of HCMSQ prior to the first dose or randomization date (if first dose date is missing) will be used. Each domain of the SoB scale is scored 1 to 6. The scores are added together to give a total score. Lower scores indicating low to no shortness of breath, higher scores indicating frequent episodes of shortness of breath. the lower the score the better. |
From First dose to week 48
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Director de estudio: Bristol-Myers Squibb, Bristol-Myers Squibb
Publicaciones y enlaces útiles
Publicaciones Generales
- Desai MY, Owens AT, Abraham T, Olivotto I, Garcia-Pavia P, Lopes RD, Elliott P, Fernandes F, Verheyen N, Maier L, Meder B, Azevedo O, Kitaoka H, Wolski K, Wang Q, Jaber W, Mitchell L, Myers J, Rano T, Gong Z, Zhong Y, Carter-Bonanza S, Florea V, Aronson R, Nissen SE; ODYSSEY-HCM Investigators. Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy. N Engl J Med. 2025 Sep 11;393(10):961-972. doi: 10.1056/NEJMoa2505927. Epub 2025 Aug 30.
- Desai MY, Nissen SE, Abraham T, Olivotto I, Garcia-Pavia P, Lopes RD, Verheyen N, Wever-Pinzon O, Wolski K, Jaber W, Mitchell L, Davey D, Myers J, Rano T, Bhatia V, Zhong Y, Carter-Bonanza S, Florea V, Aronson R, Owens AT; ODYSSEY-HCM Investigators. Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Design, Rationale, and Baseline Characteristics of ODYSSEY-HCM. JACC Heart Fail. 2025 Feb;13(2):358-370. doi: 10.1016/j.jchf.2024.11.013.
- O'Malley PA. Mavacamten (CAMZYOS) First-in-Class Small-Molecule Myosin Inhibitor for Treatment of Obstructive Hypertrophic Cardiomyopathy. Clin Nurse Spec. 2024 May-Jun 01;38(3):119-121. doi: 10.1097/NUR.0000000000000821. No abstract available.
- Desai MY, Olivotto I, Abraham T, Nissen SE, Garcia-Pavia P, Lopes RD, Elliott PM, Fernandes F, de Barros Correia E, Barriales-Villa R, Zorio E, Arad M, Shin SH, Verheyen N, Meder B, Azevedo O, Kitaoka H, Wolski K, Wang Q, Suryawanshi B, Wang Z, Florea V, Aronson R, Owens AT; ODYSSEY-HCM Investigators. Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy: Insights From the ODYSSEY-HCM Trial. J Am Coll Cardiol. 2025 Dec 16;86(24):2418-2433. doi: 10.1016/j.jacc.2025.08.017. Epub 2025 Aug 27.
- Sikand N, Stendahl J, Sen S, Lampert R, Day S. Current management of hypertrophic cardiomyopathy. BMJ. 2025 May 27;389:e077274. doi: 10.1136/bmj-2023-077274.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- CV027-031
- U1111-1269-8581 (Identificador de registro: WHO)
- 2023-506352-24 (Identificador de registro: EU CT Number)
- 2023 (Subvención/contrato del NIH de EE. UU.)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myers Squibb's data sharing policy and process can be found at: https://www.bms.com/researchers-and-partners/clinical-trials-and-research/disclosurecommitment.html
Marco de tiempo para compartir IPD
See Plan Description
Criterios de acceso compartido de IPD
See Plan Description
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- SAVIA
- RSC
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .